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• Coronavirus disease 2019 (COVID-19) caused by severe acute 
respiratory syndrome coronavirus-2 (SARS-COV-2) first 
appeared in Wuhan, China.
• The virus has since spread worldwide and is now a declared 
pandemic by World Health Organization (WHO)
• Individuals living with cardiovascular disease are at an 
increased risk for poor health outcomes related to COVID-19
• Coronary Artery Disease (CAD) aka Coronary Heart Disease
• Congestive Heart Failure (CHF) 
• Hypertension (HBP)
METHODS
• Rapid Systematic Literature Review 
PUBMED/MEDLINE electronic database
• Primary search individual or MeSH terms
(“COVID-19 OR “Coronavirus” or “SARS-CoV-2”) AND 
(“Cardiovascular”) AND (“Mortality”) OR (“Coronary 
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OBJECTIVE
• Summarize findings from literature on the impact of COVID-19 on 
patients with CAD, CHF, and HBP
• Inclusion / Exclusion criteria
Peer-reviewed studies that explored the impact of 
COVID-19 on patients with CVD 
Commentaries, review papers, studies not 
conducted on humans
Data extraction and management 
PRISMA protocol 
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RESULTS
• The rapid review suggests that patients with CAD, 
CHF and HBP are at an increased risk of COVID-
related morbidity and mortality
• It is exceedingly important for these individuals to 
follow strict social distancing, masking and stay at 
home as much as possible to avoid infection
• Patients should call their providers if they have 
concerns about their condition or feel sick
• Caregivers or people who cohabitate should pay 
attention to guidelines and precautions published by 
the CDC and WHO




Preferred Reporting Items 
for Systematic Review 
(PRISMA) flowchart for 
article selection, review of 
articles on impact of 
COVID-19 on individuals 
living with Cardiovascular 
Disease. 
9 peer reviewed papers met the inclusion criteria and were summarized for this review. 
Table 1 highlights important paper characterizes and key findings. 
• Patients with pre-existing CAD, CHF, and HBP have a higher risk of death 
from COVID-19
• HBP was found to be one of the most common comorbidities among non-
surviving COVID-19 patients
• Pre-existing HBP individuals are more likely:
• Intubated
• Require ICU care
• Die from COVID-19
• Patients with COVID and pre-existing CAD have poorer COVID related 
outcomes than those without CAD and are more likely to:
• Require ICU care
• Require invasive mechanical ventilation
• Patients with CHF have very low ejection fractions and are particularly 
challenged by COVID
• Pre-existing CHF patients are more likely to:
• Require ICU Care
• Die from COVID-19
